News About: Pharm. Industry
LG Life Sciences teams up with Sanofi-Aventis Korea
LG Life Sciences said Monday that it has established a marketing and distribution partnership with Sanofi-Aventis Korea.
Under the deal, Sanofi-Aventis Korea will be in charge of selling LGIS’s diabetes treatment G...
Ildong’s Ansung plant recognized
Ildong Pharmaceutical said last Friday that Ansung factory acquired the final recognition of the Japanese Ministry of Wealth and Labor about its sold-form facility for general and antineoplastic drug wards.
This wi...
Boryung to export new antihypertensive agent to Brazil
Boryung Pharmaceutical Co. today said it has signed an exclusive distribution agreement with Brazil’s largest drugmaker Ache Pharmaceutical, who will take care of commercializing Boryung’s new antihypertensive drug Ka...
Schnell close to buying Chunggei
Schnell Life Sciences will take over Chunggei Pharmaceutical, Schnell officials said last Thursday.
“A deal seems imminent,’’ a Schnell spokesman said. ``We believe if everything works out well, we could be signing...
Kwon named licensing executive
The Korean-based Pharmaceutical Industry Association (KRPIA) said last Tuesday it has appointed as its managing executive director, Kwon Oh-hoon, an expert known for his long-ranging career in the licensing and clinic...
National assembly audit starts tomorrow
Members of the National Assembly Health and Welfare Committee will start a 20-day inspection on government offices from tomorrow till October 24.
Lawmakers pledged to dig into the details of allegations on predator...
Samsung is yearning to be world leader, but Korean drug makers struggle to stay afloat
What should Samsung Electronics do once its legal battle with Apple ends?
The Korean firm hopes to transform from just selling its products to becoming a market creator that sells values by pursuing another type of...
Bright prospect expected for drug makers in third quarter
Optimism is growing over the third quarter outlook for Korea’ leading pharmaceutical firms as they are pushing up with co-marketing strategies with multinational firms, according to a report by Shinhan Finance & Inves...
Generic Baraclude market seen to be overheated
The domestic pharmaceutical industry is struggling with the fallout of the American pharmaceutical firm Bristol Myers Squibb (BMS)’s setback in the domestic anti-hepatitis B drug market.
Nearly 40 kinds of Baraclu...
Conflict at BMS Korea escalates over wage difference
BMS Korea's management and labor union have still far apart over the wage difference of employees.
The company said Thursday that it paid this month’s wage ducting the days of walkout per department.
However, un...
